Published in Nature on January 17, 2010
Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol (2013) 4.72
Factors affecting reproducibility between genome-scale siRNA-based screens. J Biomol Screen (2010) 4.47
IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog (2011) 2.99
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A (2014) 2.25
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Systems biology in immunology: a computational modeling perspective. Annu Rev Immunol (2011) 2.15
Viral subversion of the host protein synthesis machinery. Nat Rev Microbiol (2011) 2.07
Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol (2011) 2.06
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. Nat Chem Biol (2011) 1.98
Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J Biol Chem (2010) 1.89
Viral immune modulators perturb the human molecular network by common and unique strategies. Nature (2012) 1.86
Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding. Cell Host Microbe (2015) 1.83
Human enterovirus 71 epidemics: what's next? Emerg Health Threats J (2013) 1.54
Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods (2010) 1.53
SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell (2011) 1.52
Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. J Virol (2010) 1.46
Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers. PLoS One (2015) 1.43
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe (2011) 1.43
Influenza Virus mRNA Trafficking Through Host Nuclear Speckles. Nat Microbiol (2016) 1.41
The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect (2011) 1.32
Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest (2011) 1.32
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J (2010) 1.30
Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. MBio (2011) 1.22
Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathog (2011) 1.22
Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe (2014) 1.19
RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A (2011) 1.19
Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect (2011) 1.19
Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases. PLoS One (2011) 1.18
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol (2010) 1.16
The first influenza pandemic of the new millennium. Influenza Other Respir Viruses (2011) 1.14
Linking the signaling cascades and dynamic regulatory networks controlling stress responses. Genome Res (2012) 1.14
Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion. PLoS Pathog (2011) 1.08
Genome-wide screening using RNA interference to study host factors in viral replication and pathogenesis. Exp Biol Med (Maywood) (2011) 1.07
Mammalian phospholipase D physiological and pathological roles. Acta Physiol (Oxf) (2011) 1.06
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat Commun (2011) 1.05
The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses. PLoS One (2011) 1.05
Eph receptors and ephrins: therapeutic opportunities. Annu Rev Pharmacol Toxicol (2014) 1.04
Gene expression signature-based screening identifies new broadly effective influenza a antivirals. PLoS One (2010) 1.04
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proc Natl Acad Sci U S A (2013) 1.04
Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A (2013) 1.04
A physical interaction network of dengue virus and human proteins. Mol Cell Proteomics (2011) 1.03
GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics (2011) 1.03
Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor. J Cell Biol (2011) 1.02
Limited agreement of independent RNAi screens for virus-required host genes owes more to false-negative than false-positive factors. PLoS Comput Biol (2013) 1.01
Systematic approaches towards the development of host-directed antiviral therapeutics. Int J Mol Sci (2011) 1.01
Son maintains accurate splicing for a subset of human pre-mRNAs. J Cell Sci (2011) 1.00
Reductionistic and holistic science. Infect Immun (2011) 0.99
Overview of protein microarrays. Curr Protoc Protein Sci (2013) 0.99
Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J Virol (2011) 0.99
Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors. J Virol (2011) 0.99
Dissecting the role of COPI complexes in influenza virus infection. J Virol (2012) 0.99
Hypothemycin, a fungal natural product, identifies therapeutic targets in Trypanosoma brucei [corrected]. Elife (2013) 0.98
Alternative splicing and retinal degeneration. Clin Genet (2013) 0.98
Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). BMC Infect Dis (2013) 0.98
Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. Cell Host Microbe (2013) 0.98
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog (2013) 0.98
Cell-based genomic screening: elucidating virus-host interactions. Curr Opin Virol (2012) 0.97
The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog (2013) 0.97
Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT. J Virol (2010) 0.96
Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J Virol (2011) 0.96
MicroRNA regulation of human protease genes essential for influenza virus replication. PLoS One (2012) 0.96
F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc Natl Acad Sci U S A (2012) 0.96
Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell. RNA Biol (2013) 0.96
SON is a spliceosome-associated factor required for mitotic progression. Cell Cycle (2010) 0.95
Influenza viruses and mRNA splicing: doing more with less. MBio (2014) 0.95
New treatments for influenza. BMC Med (2012) 0.95
Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. J Virol (2011) 0.95
Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J Virol (2014) 0.94
ERK signaling couples nutrient status to antiviral defense in the insect gut. Proc Natl Acad Sci U S A (2013) 0.94
Antiviral RNAi: translating science towards therapeutic success. Pharm Res (2011) 0.94
The virus as metabolic engineer. Biotechnol J (2010) 0.94
Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export. J Cell Biol (2012) 0.94
High-content analysis of sequential events during the early phase of influenza A virus infection. PLoS One (2013) 0.94
The host interactome of influenza virus presents new potential targets for antiviral drugs. Rev Med Virol (2011) 0.94
SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J Virol (2012) 0.93
A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol (2013) 0.93
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J (2012) 0.93
An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections. Virol J (2010) 0.93
Genetic inactivation of COPI coatomer separately inhibits vesicular stomatitis virus entry and gene expression. J Virol (2011) 0.93
Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen. PLoS One (2013) 0.92
The phospholipase D superfamily as therapeutic targets. Trends Pharmacol Sci (2015) 0.92
Interactome analysis of the influenza A virus transcription/replication machinery identifies protein phosphatase 6 as a cellular factor required for efficient virus replication. J Virol (2014) 0.92
The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections. Br J Pharmacol (2011) 0.92
Dual function of CD81 in influenza virus uncoating and budding. PLoS Pathog (2013) 0.92
New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antiviral Res (2013) 0.92
Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs. PLoS One (2013) 0.91
Host modulators of H1N1 cytopathogenicity. PLoS One (2012) 0.91
Network-based prediction and analysis of HIV dependency factors. PLoS Comput Biol (2011) 0.91
Development of a cell system for siRNA screening of pathogen responses in human and mouse macrophages. Sci Rep (2015) 0.91
Identifying proteins controlling key disease signaling pathways. Bioinformatics (2013) 0.90
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog (2011) 0.90
A host of factors regulating influenza virus replication. Viruses (2010) 0.90
Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog (2013) 0.90
Conservation of RNA chaperone activity of the human La-related proteins 4, 6 and 7. Nucleic Acids Res (2013) 0.90
Driving a wedge between viral lipids blocks infection. Proc Natl Acad Sci U S A (2010) 0.89
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning. Pharmaceuticals (Basel) (2013) 0.89
Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study. J Proteome Res (2012) 0.89
High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay. World J Virol (2013) 0.89
Reactome: a knowledgebase of biological pathways. Nucleic Acids Res (2005) 20.05
The druggable genome. Nat Rev Drug Discov (2002) 13.61
Using GOstats to test gene lists for GO term association. Bioinformatics (2006) 12.58
Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell (2008) 8.41
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
Analysis of cell-based RNAi screens. Genome Biol (2006) 3.99
Discovery of insect and human dengue virus host factors. Nature (2009) 3.49
RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci U S A (2003) 3.48
A probability-based approach for the analysis of large-scale RNAi screens. Nat Methods (2007) 3.34
Improved statistical methods for hit selection in high-throughput screening. J Biomol Screen (2003) 3.15
IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol (2006) 2.93
Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev (2005) 2.83
Nuclear mRNA export: insights from virology. Trends Biochem Sci (2003) 2.79
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
A molecular link between SR protein dephosphorylation and mRNA export. Proc Natl Acad Sci U S A (2004) 2.49
Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A (2007) 2.44
Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem (2004) 2.26
Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol (1994) 2.06
Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol (1995) 1.77
Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol Med (2003) 1.64
Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods (2005) 1.62
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. Structure (2009) 1.36
Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON. J Biol Chem (2001) 1.31
Alternative splicing: a new drug target of the post-genome era. Biochim Biophys Acta (2005) 1.30
A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators. Mol Cell Proteomics (2004) 1.21
Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5' end of the viral intron. J Gen Virol (2005) 1.09
Influenza A replication and host nuclear compartments: many changes and many questions. J Clin Virol (2008) 1.07
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98
Qualimap: evaluating next-generation sequencing alignment data. Bioinformatics (2012) 3.62
Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem (2002) 3.47
Late recovery following spinal cord injury. Case report and review of the literature. J Neurosurg (2002) 3.21
IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol (2006) 2.93
Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature (2006) 2.78
A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med (2002) 2.75
Type IV secretion systems and their effectors in bacterial pathogenesis. Curr Opin Microbiol (2006) 2.65
Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet (2005) 2.61
Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med (2006) 2.53
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol (2005) 2.41
Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol (2010) 2.39
Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis (2012) 2.38
Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol (2003) 2.37
Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol (2006) 2.32
Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome. Nucleic Acids Res (2009) 2.20
Helicobacter pylori genome evolution during human infection. Proc Natl Acad Sci U S A (2011) 2.15
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol (2002) 2.14
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med (2009) 2.12
Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature (2008) 2.04
Genome-wide analysis of transcriptional hierarchy and feedback regulation in the flagellar system of Helicobacter pylori. Mol Microbiol (2004) 1.97
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog (2008) 1.94
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol (2006) 1.94
Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med (2004) 1.89
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res (2009) 1.84
Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun (2002) 1.84
The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog (2010) 1.79
Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci U S A (2012) 1.79
From the inside out--processing of the Chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells. Mol Microbiol (2004) 1.78
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol (2006) 1.77
Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J Biol Chem (2002) 1.76
Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog (2013) 1.74
Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol (2008) 1.73
Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol (2006) 1.70
Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun (2002) 1.70
Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect Immun (2004) 1.66
Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol Med (2003) 1.64
Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics (2002) 1.63
Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice. J Invest Dermatol (2008) 1.62
The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol (2004) 1.61
The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J (2003) 1.60
NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem (2004) 1.59
Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect Immun (2002) 1.59
Failure to detect Borna disease virus antigen and RNA in human blood. J Clin Virol (2006) 1.59
Type IV pilus retraction in pathogenic Neisseria is regulated by the PilC proteins. EMBO J (2004) 1.57
Characterization of the ArsRS regulon of Helicobacter pylori, involved in acid adaptation. J Bacteriol (2006) 1.54
Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events. Heart Rhythm (2009) 1.52
Comparative genomics and transcriptomics of Propionibacterium acnes. PLoS One (2011) 1.52
MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immunol (2011) 1.50
Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A (2005) 1.49
Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett (2004) 1.47
Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol (2010) 1.45
Interplay between influenza A virus and the innate immune signaling. Microbes Infect (2009) 1.43
Influenza B virus with modified hemagglutinin cleavage site as a novel attenuated live vaccine. J Infect Dis (2011) 1.40
The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol (2004) 1.39
IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS One (2009) 1.38
Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe (2013) 1.35
Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One (2010) 1.35
Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence. PLoS Pathog (2007) 1.33
The autodisplay story, from discovery to biotechnical and biomedical applications. Microbiol Mol Biol Rev (2007) 1.32
Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol (2006) 1.31
Rab6 and Rab11 regulate Chlamydia trachomatis development and golgin-84-dependent Golgi fragmentation. PLoS Pathog (2009) 1.31
siRNA stabilization prolongs gene knockdown in primary T lymphocytes. Eur J Immunol (2008) 1.30
Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol (2007) 1.30
N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. J Gen Virol (2002) 1.29
Proteomic identification of secreted proteins of Propionibacterium acnes. BMC Microbiol (2010) 1.28
Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J Virol (2010) 1.28
The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages. Mol Biol Cell (2006) 1.27
Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells. PLoS One (2008) 1.26
'Small' talk: Opa proteins as mediators of Neisseria-host-cell communication. Curr Opin Microbiol (2003) 1.26
Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol (2003) 1.25
The prevention and control of HIV/AIDS, TB and Vector-borne diseases in informal settlements: challenges, opportunities and insights. J Urban Health (2007) 1.24
CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection. J Virol (2004) 1.23
Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction. PLoS Pathog (2010) 1.23
Sam50 functions in mitochondrial intermembrane space bridging and biogenesis of respiratory complexes. Mol Cell Biol (2012) 1.22
Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res (2002) 1.22
CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells. Infect Immun (2005) 1.22
Bak and Bax are non-redundant during infection- and DNA damage-induced apoptosis. EMBO J (2007) 1.21
A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators. Mol Cell Proteomics (2004) 1.21
Conserved roles of Sam50 and metaxins in VDAC biogenesis. EMBO Rep (2007) 1.20
The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol (2009) 1.20
Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol (2012) 1.19
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol (2007) 1.17
IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells. PLoS Pathog (2006) 1.17